ATAGI recommendations 

Coversheet on evidence assessment: CVD 103–HgR (Vaxchora) in children and adults 

Use of CVD 103–HgR (Vaxchora) cholera vaccine compared to placebo in children and adults aged ≥2 years who have a high risk of exposure to cholera

 

GRADE assessment for CVD 103–HgR (Vaxchora)

Compared to placebo in children and adults aged ≥2 years who have a high risk of exposure to cholera

 

Note: These GRADE documents should be read as a supplement to Australian Immunisation Handbook recommendations.

 View the cholera disease chapter in the Australian Immunisation Handbook

Last updated February 2024